Omnicare Sets New 1-Year High at $64.62 (OCR)
Omnicare (NYSE:OCR) shares hit a new 52-week high on Thursday , American Banking News reports. The company traded as high as $64.62 and last traded at $64.62, with a volume of 1,040,895 shares trading hands. The stock had previously closed at $62.70.
OCR has been the subject of a number of recent research reports. Analysts at UBS AG raised their price target on shares of Omnicare from $53.00 to $64.00 in a research note on Friday, January 24th. They now have a “neutral” rating on the stock. Separately, analysts at Barclays raised their price target on shares of Omnicare from $60.00 to $66.00 in a research note on Wednesday, January 8th. They now have an “equal weight” rating on the stock. Finally, analysts at Goldman Sachs raised their price target on shares of Omnicare from $59.00 to $62.00 in a research note on Tuesday, December 17th. Two investment analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. The stock has an average rating of “Buy” and an average target price of $62.00.
The stock has a 50-day moving average of $61.84 and a 200-day moving average of $57.47. The company has a market cap of $6.619 billion and a price-to-earnings ratio of 69.13.
Omnicare, Inc (NYSE:OCR) is a healthcare services company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.